TY  - JOUR
AU  - Merlo, Anna
AU  - Bernardo-Castiñeira, Cristóbal
AU  - Sáenz-de-Santa-María, Inés
AU  - Pitiot, Ana S
AU  - Balbín, Milagros
AU  - Astudillo, Aurora
AU  - Valdés, Nuria
AU  - Scola, Bartolomé
AU  - Del Toro, Raquel
AU  - Méndez-Ferrer, Simón
AU  - Piruat, José I
AU  - Suarez, Carlos
AU  - Chiara, María-Dolores
PY  - 2017
DO  - 10.18632/oncotarget.14265
UR  - https://hdl.handle.net/10668/25126
T2  - Oncotarget
AB  - The hypoxia-inducible factor 1α (HIF-1α) and its microRNA target, miR-210, are candidate tumor-drivers of metabolic reprogramming in cancer. Neuroendocrine neoplasms such as paragangliomas (PGLs) are particularly appealing for understanding the cancer...
LA  - en
KW  - hypoxia inducible factor
KW  - miR-210
KW  - paragangliomas
KW  - succinate dehydrogenase
KW  - von hippel lindau
KW  - Adult
KW  - Animals
KW  - Cell Line, Tumor
KW  - Female
KW  - Gene Deletion
KW  - Gene Expression Regulation, Neoplastic
KW  - Genetic Predisposition to Disease
KW  - Humans
KW  - Hypoxia-Inducible Factor 1, alpha Subunit
KW  - Male
KW  - Mice, Knockout
KW  - MicroRNAs
KW  - Mutation
KW  - Paraganglioma
KW  - Phenotype
KW  - Protein Stability
KW  - RNA Interference
KW  - Signal Transduction
KW  - Succinate Dehydrogenase
KW  - Transfection
KW  - Tumor Hypoxia
KW  - Tumor Microenvironment
KW  - Von Hippel-Lindau Tumor Suppressor Protein
TI  - Role of VHL, HIF1A and SDH on the expression of miR-210: Implications for tumoral pseudo-hypoxic fate.
TY  - research article
VL  - 8
ER  -